-transparent.png){kind=logo}
Six patients with chronic liver disease and six sex-, age (+/- 5 years)-, and weight (+/- 5 kg)-matched healthy control subjects received a single dose of two 100 mg tablets rimantadine HCl. Eight additional patients with chronic liver disease who were not matched to healthy subjects received a single dose of two 100 mg tablets of rimantadine HCl. Blood and urine samples were collected and rimantadine concentrations were determined by a GCMS method. The values for maximum plasma concentration, AUC, elimination half-life, and renal clearance were not significantly different between patients and control subjects, independent of the statistical analyses (parametric and nonparametric) used. The mean apparent elimination half-life, volume of distribution, and total clearance in the matched patients with liver disease were 32 hours, 24 L/kg, and 676 ml/min, respectively. Renal clearance and the amount excreted in the urine unchanged were 63 ml/min and 10%, respectively. In conclusion, rimantadine pharmacokinetics were not appreciably altered in patients with less severe chronic liver disease.
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
November 1988,
Antimicrobial agents and chemotherapy,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
March 1983,
Antimicrobial agents and chemotherapy,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
August 1985,
Antimicrobial agents and chemotherapy,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
January 1996,
Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
January 1990,
European journal of clinical pharmacology,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
October 1996,
Journal of clinical pharmacology,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
November 2005,
Se pu = Chinese journal of chromatography,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
August 2001,
Journal of gastroenterology and hepatology,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
November 1992,
International journal of clinical pharmacology, therapy, and toxicology,
R J Wills, and
R Belshe, and
D Tomlinsin, and
F De Grazia, and
A Lin, and
S Wells, and
J Milazzo, and
C Berry
February 1982,
Gastroenterologie clinique et biologique,
